Dreal | Control | |
---|---|---|
Age | 58 years (range 40–84) | 59 years (range 29–83) |
Sex | ||
Female | 16 (37%) | 5 (50%) |
Male | 27 (63%) | 5 (50%) |
Smoking status | ||
Yes | 14 (33%) | 2 (20%) |
No | 29 (67%) | 8 (80%) |
Procedure type | ||
ACCF | 32 (74%) | |
ACCF + ACDF at adjacent level | 10 (23%) | 8 (80%) |
ACCF, skip level | 1 (2%) | |
Two-level ACCF | 2 (20%) | |
Resected level | ||
C4 | 10 (23%) | 1 (10%) |
C5 | 13 (30%) | 4 (40%) |
C6 | 19 (44%) | 3 (30%) |
C4 + C6 | 1 (2%) | |
C5 + C6 | 2 (20%) | |
Indication | ||
Cervical myelopathy | 34 (79%) | 9 (90%) |
Cervical myelopathy and radiculopathy | 9 (21%) | 1 (10%) |
Comorbidities | ||
Diabetes | 5 (12%) | 1 (10%) |
Cardiac disease | 7 (16%) | 1 (10%) |
Coagulation disorders | 1 (2%) | |
Chronic obstructive pulmonary disease (COPD) | 5 (12%) | 3 (30%) |
Hypertension | 14 (33%) | 3 (30%) |
Obesity | 1 (2%) | |
Osteoporosis | 2 (20%) |